Search results
Author(s):
Harriette Van Spall
,
Mandeep Mehra
Added:
4 months ago
AHA 23 - Investigator, Dr Mandeep R Mehra (Brigham and Women's Hospital and Harvard Medical School, US) is joined by Late-breaker host, Dr Harriette Van Spall (McMaster University, CA) to discuss the ARIES HM3 trial.ARIES HM3 is a prospective, randomised, double-blinded, placebo-controlled clinical investigation into heart failure (HF) patients treated with the ARIES HeartMate 3 pump, who were…
View more
Author(s):
Jack Copeland
Added:
3 years ago
Mechanical circulatory support (MCS) devices are changing heart failure therapy. A spectrum of devices have become essential to the management of a variety of heart failure scenarios and, in the next few decades, this spectrum will expand and improve thousands of lives each year. The field has grown slowly and at considerable cost over the past 50 years but is now moving rapidly. Devices as small…
View more
Author(s):
Alex F Warren
,
Carolyn Rosner
,
Raghav Gattani
,
et al
Added:
2 years ago
Author(s):
Michael T Cain
,
Michael S Firstenberg
,
Joseph C Cleveland Jr
Added:
2 years ago
Author(s):
Marvin J Slepian
Added:
3 years ago
Heart failure remains the final common pathway of all forms of heart disease. Currently, more than 20 million patients suffer with heart failure in the US and Europe combined.1 Over the past two decades, advances in medical therapeutics have made inroads in reducing mortality associated with early- and mid-stage heart failure. Unfortunately, once patients progress to advanced heart failure, i.e…
View more
Author(s):
Kari Gorder
,
Steve Rudick
,
Timothy D Smith
Added:
2 years ago
Author(s):
Kiran K Khush
,
Sharon A Hunt
Added:
3 years ago
The field of heart transplantation has evolved tremendously since Alexis Carrel first explanted a canine heart and anastomosed it to the carotid artery and jugular vein of a recipient dog in 1905.1 In 1960, Norman Shumway and Richard Lower at Stanford described a technique for orthotopic canine heart transplantation and demonstrated adequate physiologic function of the denervated heart.2 Their…
View more
LVAD as Destination Therapy
Author(s):
Jorge Silva Enciso
,
Eric Adler
,
Barry H Greenberg
Added:
3 years ago
Article
Author(s):
Andrea Elliott
,
Garima Dahyia
,
Rajat Kalra
,
et al
Added:
2 years ago
Author(s):
James N Kirkpatrick
,
Susan E Wiegers
,
J Eduardo Rame
,
et al
Added:
3 years ago
There are at least five million patients with heart failure (HF) in the US, 5% of whom are considered end-stage.1 Mechanical circulatory support (MCS) in the form of ventricular assist devices (VADs) is becoming an increasingly important option for these patients. Previously reserved for rescuing patients in the throes of refractory cardiogenic shock, MCS is now a mainstay of end-stage heart…
View more